The head of one of the world’s biggest vaccine companies says Europe needs to wake up to the challenge of manufacturing enough coronavirus shots to halt the pandemic.
As others squabble over the timing and details of how to develop such a vaccine, Sanofi Chief Executive Officer Paul Hudson points further ahead to the continent’s ability to produce enough to meet demand. “There is less concern about finding a successful vaccine than there is about making the volumes needed," Hudson told reporters on Friday. “The biggest untold story in Europe right now is the one about the number of doses." Sanofi is working with rival GlaxoSmithKline Plc to develop a vaccine against the new coronavirus, racing against other pharma giants such as Johnson &